Literature DB >> 28653867

Association Between the Single Assessment Numeric Evaluation and the Western Ontario and McMaster Universities Osteoarthritis Index.

Brian Pietrosimone1,2, Brittney A Luc1,2, Austin Duncan1, Susan A Saliba3, Joseph M Hart3, Christopher D Ingersoll4.   

Abstract

CONTEXT: Patient-reported outcomes (PROs) evaluate how patients describe symptoms as well as level of physical function or quality of life. The Western Ontario and McMaster Universities Osteoarthritis (WOMAC) Index is one of the most common PROs used to assess disability in patients with knee osteoarthritis (OA), yet the Single Assessment Numeric Evaluation (SANE) is a single-question instrument that may improve the efficiency associated with the measurement of patient function.
OBJECTIVE: To determine the associations between (1) SANEFunction and the physical dysfunction subsection of the WOMAC index (WOMACDysfunction) before rehabilitation and after a 4-week therapeutic exercise intervention as well as (2) the percentage change in SANEFunction and WOMACDysfunction in people with knee OA after 4 weeks of therapeutic exercise.
DESIGN: Cross-sectional study.
SETTING: Research laboratory. PATIENTS OR OTHER PARTICIPANTS: Thirty-six participants (15 men, 21 women) with radiographic knee OA. INTERVENTION(S): Participants completed 12 sessions (over a 4-week period) of therapeutic exercise to strengthen the lower extremity. MAIN OUTCOME MEASURE(S): The SANEFunction and WOMACDysfunction (WOMACDysfunction normalized to 100%) scores were collected before and after the 4-week intervention. Percentage change scores over the 4-week intervention were calculated for both measures.
RESULTS: Participants with a higher SANEFunction score demonstrated a lower WOMACDysfunction score at baseline (rs = -0.44, P = .007) and at the 4-week time point (rs = -0.69, P < .001). There was a nonsignificant and weak association between the changes in the SANEFunction and WOMACDysfunction scores over the 4 weeks of therapeutic exercise (rs = -0.17, P < .43).
CONCLUSIONS: The SANEFunction and WOMACDysfunction scores demonstrated moderate to weak associations before and after a 4-week exercise program, respectively, whereas the changes in SANEFunction and WOMACDysfunction scores were not associated. These PROs may be measuring different aspects of self-reported function and therefore should not be used interchangeably to determine a therapeutic response.

Entities:  

Keywords:  disability; patient-reported outcomes; physical function; quality of life

Mesh:

Year:  2017        PMID: 28653867      PMCID: PMC5488843          DOI: 10.4085/1062-6050-52.5.07

Source DB:  PubMed          Journal:  J Athl Train        ISSN: 1062-6050            Impact factor:   2.860


  35 in total

1.  Isolated tears of the anterior cruciate ligament: over 30-year follow-up of patients treated with arthrotomy and primary repair.

Authors:  Dean C Taylor; Matthew Posner; Walton W Curl; John A Feagin
Journal:  Am J Sports Med       Date:  2008-11-24       Impact factor: 6.202

Review 2.  The measurement properties of the IKDC-subjective knee form.

Authors:  Hanna Tigerstrand Grevnerts; Caroline B Terwee; Joanna Kvist
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-09-06       Impact factor: 4.342

3.  The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study.

Authors:  Marita Cross; Emma Smith; Damian Hoy; Sandra Nolte; Ilana Ackerman; Marlene Fransen; Lisa Bridgett; Sean Williams; Francis Guillemin; Catherine L Hill; Laura L Laslett; Graeme Jones; Flavia Cicuttini; Richard Osborne; Theo Vos; Rachelle Buchbinder; Anthony Woolf; Lyn March
Journal:  Ann Rheum Dis       Date:  2014-02-19       Impact factor: 19.103

4.  A concordance correlation coefficient to evaluate reproducibility.

Authors:  L I Lin
Journal:  Biometrics       Date:  1989-03       Impact factor: 2.571

Review 5.  Impact of patient-reported outcome measures on routine practice: a structured review.

Authors:  Susan Marshall; Kirstie Haywood; Ray Fitzpatrick
Journal:  J Eval Clin Pract       Date:  2006-10       Impact factor: 2.431

6.  Stability results of hamstring anterior cruciate ligament reconstruction at 2- to 8-year follow-up.

Authors:  Chadwick C Prodromos; Yung S Han; Brett L Keller; Richelle J Bolyard
Journal:  Arthroscopy       Date:  2005-02       Impact factor: 4.772

7.  Patient reported outcome measures could help transform healthcare.

Authors:  Nick Black
Journal:  BMJ       Date:  2013-01-28

8.  The incidence and outcome of patella fractures after anterior cruciate ligament reconstruction.

Authors:  Drew A Stein; Stephen A Hunt; Jeffrey E Rosen; Orrin H Sherman
Journal:  Arthroscopy       Date:  2002 Jul-Aug       Impact factor: 4.772

9.  EQ-5D and SF-36 quality of life measures in systemic lupus erythematosus: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, and fibromyalgia.

Authors:  Frederick Wolfe; Kaleb Michaud; Tracy Li; Robert S Katz
Journal:  J Rheumatol       Date:  2009-12-23       Impact factor: 4.666

10.  Quadriceps strengthening with the DAPRE technique: case studies with neurological implications.

Authors:  K L Knight
Journal:  Med Sci Sports Exerc       Date:  1985-12       Impact factor: 5.411

View more
  3 in total

Review 1.  Correlation of Single Assessment Numeric Evaluation (SANE) with other Patient Reported Outcome Measures (PROMs).

Authors:  Casey M O'Connor; David Ring
Journal:  Arch Bone Jt Surg       Date:  2019-07

2.  Assessing the Patient-Perceived Monetary Value of Patient-Reported Outcome Improvement for Patients With Chronic Knee Conditions.

Authors:  Sarah B Floyd; Alicia Oostdyk; Melanie Cozad; John M Brooks; Paul Siffri; Brian Burnikel
Journal:  J Patient Cent Res Rev       Date:  2021-04-19

3.  The subjective knee value is a valid single-item survey to assess knee function in common knee disorders.

Authors:  Fabian Plachel; Tobias Jung; Benjamin Bartek; Katja Rüttershoff; Carsten Perka; Clemens Gwinner
Journal:  Arch Orthop Trauma Surg       Date:  2021-02-01       Impact factor: 2.928

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.